The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) has awarded a $20 billion Indefinite Delivery Contract to Advanced Technology International (ATI), a public service nonprofit, to establish and manage the Biopharmaceutical Manufacturing Preparedness Consortium (BIOMAP-Consortium). The consortium aims to build domestic manufacturing capabilities for medical countermeasures like vaccines, therapeutics, and personal protective equipment (PPE).
Under this IDV, ATI has received several delivery orders worth over $450 million to date. These include production of drug substances/products, expansion of injection molded pipette tips/centrifuge tubes, sustainment of PPE capacities for nitrile butadiene rubber, development of sterilization capabilities, and manufacturing of biologically derived starting materials/APIs. The contracts utilize cost-plus-fixed-fee and firm-fixed-price pricing, with no set-asides. ATI frequently partners with subsidiaries and industry consortia to deliver specialized engineering, prototyping, testing, and advisory services to government agencies.
Generated 9/26/24, 9:06 AM